Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies
- DOI
- 10.1038/bjc.2014.72
- Published
- 2014-03-04
- Container
- British Journal of Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/bjc.2014.72,
title = {Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies},
author = {D Tural and S Serdengecti and F Demirelli and T Öztürk and S İlvan and H Turna and M Özgüroglu and E Büyükünal},
year = {2014},
journal = {British Journal of Cancer},
doi = {10.1038/bjc.2014.72},
url = {https://doi.org/10.1038/bjc.2014.72}
}RIS
TY - JOUR TI - Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies AU - D Tural AU - S Serdengecti AU - F Demirelli AU - T Öztürk AU - S İlvan AU - H Turna AU - M Özgüroglu AU - E Büyükünal PY - 2014 JO - British Journal of Cancer DO - 10.1038/bjc.2014.72 UR - https://doi.org/10.1038/bjc.2014.72 ER -
APA
Tural, D., Serdengecti, S., Demirelli, F., Öztürk, T., İlvan, S., Turna, H., Özgüroglu, M., & Büyükünal, E. (2014). Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies. British Journal of Cancer. https://doi.org/10.1038/bjc.2014.72
Source records
- crossref · retrieved 2026-09-24T22:44:15.688Z